Antagonizing role of adiponectin against leptin helps to explain how a decrease in adiponectin/leptin ratio increases the risk of cancers such as colorectal, prostate, hepatic, endometrial, and breast [67, 68]. This evidence concerns the gene ADIPOQ and cancer.